Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MENDING: Intravenous Guanfacine for ICU Delirium
NCT04742673Phase 2Completed
- Sponsor
- Vanderbilt University Medical Center
- Start
- May 2021
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of guanfacine in delirium, sponsored by Vanderbilt University Medical Center. Started May 2021; status: completed.
02
Drugs
guanfacine
03
Conditions
delirium
Beyond the preview
Go deeper on NCT04742673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04742673.